Vaccine Hesitancy Persists Despite Delta Variant

Bloomberg Businessweek

Rupali Limaye, Associate Director for Behavioral Research for the Institute for Vaccine Safety at the Johns Hopkins Bloomberg School of Public Health, explains why some are hesitant to get the Covid vaccine as even as the delta variant has lead to surging cases. Bloomberg Businessweek Editor Joel Weber and Businessweek Features Editor Jeremy Keehn share the Businessweek Magazine cover story Builder Who Spent $30 Million on Trump’s Wall Is Looking to Sell. Bloomberg News U.S. Semiconductor & Networking Reporter Ian King discusses why chipmakers cranking up production to address shortages may lead to overshooting demand. And we Drive to the Close with Matt Forester, Chief Investment Officer of Lockwood at BNY Mellon’s Pershing.

Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.

See omnystudio.com/listener for privacy information.